Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Arthritis Care & Research|March 21, 2017
Health-Related Quality of Life in an Inception Cohort of Children With Juvenile Idiopathic Arthritis: A Longitudinal AnalysisKiem Oen, Jaime Guzman, Brenden Dufault, et al.
The Journal of Rheumatology|February 17, 2012
Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophil cytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe)Kimberly Morishita, Suzanne C Li, Eyal Muscal, et al.
Annals of the Rheumatic Diseases|February 15, 2025
Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations from an international task forceVeronika Rypdal, Hermine I Brunner, Brian M Feldman, et al.
Arthritis Care & Research|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and ImagingKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic ArthritisKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.
Rheumatology (Oxford, England)|January 11, 2020
Clinical and associated inflammatory biomarker features predictive of short-term outcomes in non-systemic juvenile idiopathic arthritisElham Rezaei, Daniel Hogan, Brett Trost, et al.
Annals of the Rheumatic Diseases|May 21, 2014
The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohortJaime Guzman, Kiem Oen, Lori B Tucker, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and ImagingKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.
Arthritis Care & Research|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic ArthritisKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.
The Journal of Rheumatology|August 4, 2012
Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisionsKimberly Morishita, Jaime Guzman, Peter Chira, et al.
Pageof 11